DXCM Nov 2024 155.000 call
| Previous close | 6.23 |
| Open | 6.10 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 155.00 |
| Expiry date | 2024-11-15 |
| Day's range | 6.10 - 6.23 |
| Contract range | N/A |
| Volume | |
| Open interest | 100 |
ZacksWhy DexCom (DXCM) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Simply Wall St.With EPS Growth And More, DexCom (NASDAQ:DXCM) Makes An Interesting Case
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Business WireDexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
LONDON, May 20, 2024--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM device that easily tracks real-time glucose readings to help improve diabetes management, and the Dexcom State of Type 2 Report. The report is a first-of-its-kind look at the Type 2 landscape today and examines the preferences and behaviours of those living with the condition, as well as their caretaker
